PerkinElmer Inc.

NYSE: PKI · Real-Time Price · USD
115.24
-1.06 (-0.91%)
At close: May 15, 2023, 10:03 PM

PerkinElmer Revenue Breakdown

Period Ending Dec 29, 2024 Jan 2, 2022 Jan 3, 2021 Dec 29, 2019 Dec 30, 2018 Dec 31, 2017 Jan 1, 2017
Diagnostics Revenue 1.5B 961.32M 283.43M 175.33M 160.19M 142.44M 139.74M
Diagnostics Revenue Growth +56.13% +239.17% +61.66% +9.45% +12.46% +1.93% n/a
Life Sciences Revenue 1.25B n/a n/a n/a n/a n/a n/a
Life Sciences Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 29, 2024 Jan 1, 2023 Jan 2, 2022 Jan 3, 2021 Dec 29, 2019 Dec 30, 2018 Dec 31, 2017 Jan 1, 2017 Jan 3, 2016 Dec 28, 2014 Dec 29, 2013 Dec 30, 2012 Jan 1, 2012
China Revenue 450.01M 476.37M 670.08M 492.28M 581.69M 559.87M 374.93M 336.73M 312.92M 276.23M 254.84M 216.43M 164M
China Revenue Growth -5.53% -28.91% +36.12% -15.37% +3.90% +49.32% +11.35% +7.61% +13.28% +8.39% +17.75% +31.96% n/a
Other International Revenue 2.75B 1.55B 2.05B 1.27B 974.19M 906.4M 837.02M 842.36M 916.31M 849.36M 835.64M 822.95M 728.63M
Other International Revenue Growth +77.91% -24.45% +61.26% +30.29% +7.48% +8.29% -0.63% -8.07% +7.88% +1.64% +1.54% +12.95% n/a
United Kingdom Revenue 112.88M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United Kingdom Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 1.1B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 29, 2025 Mar 30, 2025 Dec 29, 2024 Sep 29, 2024 Jun 30, 2024 Jul 2, 2023 Apr 2, 2023 Jan 1, 2023 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Jan 2, 2022 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Jan 3, 2021 Oct 4, 2020 Jul 5, 2020 Apr 5, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 30, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Jan 1, 2017 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016 Jan 3, 2016 Oct 4, 2015 Jun 28, 2015 Mar 29, 2015
Selling, General, and Administrative Revenue 248.53M 249.72M 234.17M 237.52M 251.65M 267.02M 248.56M 244.32M 239.97M 330.02M 334.39M 355.25M 339.05M 281.82M 251.41M 263.05M 225.25M 221.03M 208.57M 210.74M 204.17M 201.55M 198.86M 210.54M 196.77M 204.88M 199.72M 172.27M 150.86M 147.94M 145.09M 162.79M 145.79M 153.99M 147.54M 158.5M 147.73M 146.74M 145.87M
Selling, General, and Administrative Revenue Growth -0.48% +6.64% -1.41% -5.61% -5.76% +7.43% +1.73% +1.82% -27.29% -1.31% -5.87% +4.78% +20.31% +12.10% -4.43% +16.78% +1.91% +5.97% -1.03% +3.22% +1.30% +1.36% -5.55% +7.00% -3.96% +2.58% +15.94% +14.19% +1.97% +1.96% -10.87% +11.66% -5.33% +4.37% -6.91% +7.30% +0.67% +0.60% n/a
Research and Development Revenue 53.27M 53.6M 28.36M 49.14M 48.13M 57.25M 56.69M 54.54M 53.52M 73.35M 76.61M 80.32M 68.61M 65.82M 60.22M 56.82M 50.13M 49.52M 48.91M 47.64M 45.38M 48.34M 47.98M 51.97M 48.85M 47.2M 45.98M 37.67M 34.89M 33.56M 33.29M 32.93M 33.17M 35.01M 33.78M 30.03M 31.09M 32.68M 32.12M
Research and Development Revenue Growth -0.61% +88.95% -42.28% +2.10% -15.93% +0.99% +3.95% +1.90% -27.04% -4.25% -4.62% +17.07% +4.23% +9.31% +5.97% +13.35% +1.23% +1.24% +2.68% +4.98% -6.14% +0.76% -7.68% +6.39% +3.50% +2.64% +22.08% +7.97% +3.95% +0.82% +1.10% -0.75% -5.23% +3.62% +12.50% -3.42% -4.86% +1.75% n/a